江苏
在快速变化的医学领域，心血管疾病的防治始终是研究的热点和难点。第十八届东方心脏病学会议（The 18th Oriental Congress of Cardiology，OCC 2024）与世界心脏病学大会（World Congress of Cardiology，WCC 2024）的召开，为我们提供了一个绝佳的契机，来深度挖掘和探讨复方药片在心血管疾病治疗中的潜力。
届时，全球顶尖的医学专家们将齐聚固定剂量联合疗法和复方药片论坛，围绕复方药片在心血管疾病治疗中的应用进行深入交流。他们将共同探讨复方药片在降低心血管疾病死亡率方面的实际效果和未来发展前景，为心血管疾病的防治提供新的思路和方法。
In the rapidly evolving field of medicine, the prevention and treatment of cardiovascular diseases remain a hot topic and a difficult challenge. The convening of the 18th Oriental Congress of Cardiology (OCC 2024) and the World Congress of Cardiology (WCC 2024) presents an excellent opportunity for us to delve deeply into and explore the potential of combination drug tablets in the treatment of cardiovascular diseases.
At that time, top medical experts worldwide will gather to engage in intensive discussions surrounding the application of combination drug tablets in cardiovascular disease treatment. They will jointly deliberate on the practical effects and future prospects of these tablets in reducing cardiovascular disease mortality, providing novel ideas and methods for the prevention and treatment of cardiovascular diseases.
论坛名称：WCC-固定剂量联合疗法和复方药片论坛
论坛时间：2024年6月27日 星期四
论坛地点：上海国际会议中心明珠厅
论坛坛主：美国哈佛大学公共卫生学院Thomas Gaziano教授；
南京医科大学第一附属医院李新立教授
Forum Name：WCC-Fixed-dose combination therapies and polypill Forum
Forum Date: Thursday ,June 27, 2024 ；
Forum Venue: Pearl Hall，Shanghai International Conference Centre
Forum Chairs:
Professor Thomas Gaziano, Harvard Medical School;
Professor Li Xinli, The First Affiliated Hospital of Nanjing Medical University
Thomas Gaziano
李新立教授
治疗依从性的衡量
A measure of treatment adherence
平衡心血管药物治疗的依从性和临床惯性对于心血管疾病的管理至关重要。固定剂量联合疗法和复方药品通过多药联合，能够减少药物种类和剂量，简化治疗方案，同时有助于减少药物间的相互作用，进一步提升患者的依从性和长期治疗效果。
布宜诺斯艾利斯大学 Vilma Irazola教授将重点围绕治疗依从性和临床惯性之间的平衡，帮助临床医生和患者共同实现心血管疾病药物治疗的最优解决方案。
Balancing compliance and clinical inertia with cardiovascular drug therapy is essential for the management of cardiovascular diseases. Fixed-dose combination therapy and combination drugs can reduce the type and dose of drugs, simplify the treatment plan, and help to reduce the interaction between drugs, and further improve patient compliance and long-term treatment effect.
Professor Vilma Irazola from University of Buenos Aires will focus on the balance between treatment compliance and clinical inertia, helping clinicians and patients to achieve the optimal solution for cardiovascular diseases.
二级预防的实证
The evidence of secondary prevention
固定剂量联合疗法和复方药片在心血管疾病的二级预防中扮演着核心角色。前者通过精确组合多种药物，为患者提供全面而有效的治疗，以控制心血管疾病的风险因素；而后者则将不同药物整合为单一制剂，简化治疗流程，提高患者的用药依从性。
西班牙国家心血管研究中心José Maria Castellano Vázquez教授将仔细剖析二级预防心血管死亡率降低的证据，展示固定剂量联合疗法和复方药片在降低心血管疾病死亡率方面的显著效果，为制定更为科学、合理的治疗方案提供了有力的支持。
Fixed-dose combination therapy and polypills play a pivotal role in the secondary prevention of cardiovascular diseases. The former provides comprehensive and effective treatment for patients by precisely combining multiple drugs to control risk factors for cardiovascular diseases, while the latter integrates different drugs into a single formulation, simplifying the treatment process and improving patients' medication adherence.
Professor José Maria Castellano Vázquez from Spanish National Centre for Cardiovascular Research will carefully analyze the evidence of reduced cardiovascular mortality in secondary prevention, demonstrating the significant effects of fixed-dose combination therapy and polypills in reducing cardiovascular mortality. This provides strong support for developing more scientific and rational treatment plans.
政策实施的挑战
Challenges in policy implementation
在推广固定剂量联合疗法和复方药片以降低心血管疾病死亡率的过程中，政策实施面临着多重壁垒。伦敦卫生与热带医学学院Adrianna Murphy教授将深入探讨这些挑战，揭示诸如药物审批流程的复杂性、医疗资源分配不均以及患者用药意识和经济能力差异等关键障碍，为理解并解决这些壁垒提供重要的见解和策略。
In the process of promoting fixed-dose combination therapy and polypills to reduce cardiovascular disease mortality, policy implementation faces multiple barriers. Professor Adrianna Murphy from London School of Hygiene and Tropical Medicine will delve deeply into these challenges, revealing key obstacles such as the complexity of drug approval processes, uneven distribution of medical resources, and differences in patients' medication awareness and economic capabilities. She will provide important insights and strategies for understanding and addressing these barriers.
心脏治疗的新策略
New Strategies for Heart Treatment
在美洲地区，心血管疾病长期以来一直是危害人们健康的首要元凶。随着医学研究的不断深化和医疗技术的飞速发展，心脏治疗领域也在不断革新和突破。近年来，复方药丸作为一种综合治疗心血管疾病的创新手段，逐渐崭露头角，并引起了广泛的关注。
泛美卫生组织Pedro Orduñez教授将深入剖析并介绍在美洲心脏治疗中纳入复方药丸的重要性与可行性,这不仅将为美洲地区心血管疾病的防治提供新的思路和方法，还将为全球心血管健康领域的研究人员和临床医生提供宝贵的参考和借鉴。
In the Americas, cardiovascular diseases have long been the leading cause of health hazards. With the continuous deepening of medical research and rapid development of medical technology, the field of heart treatment is constantly innovating and breaking new ground. In recent years, polypills, as an innovative means of comprehensive treatment for cardiovascular diseases, have gradually emerged and attracted widespread attention.
Professor Pedro Orduñez from Pan American Health Organization will delve deeply into and introduce the importance and feasibility of incorporating polypills into heart treatment in the Americas. This will not only provide new ideas and methods for the prevention and treatment of cardiovascular diseases in the Americas, but also offer valuable references and insights for researchers and clinicians in the global cardiovascular health field.
我们满怀热忱地期待WCC-固定剂量联合疗法和复方药片论坛这场学术盛宴。论坛将汇聚业界精英，共同探讨复方药片在心血管健康领域的巨大潜力，以及它们如何在未来十年内显著降低心血管疾病的死亡率。我们坚信，这次论坛将为心血管健康事业带来新的启示和动力，共同迈向一个更加健康、更加繁荣的未来。
We eagerly anticipate the academic extravaganza of the WCC Fixed-Dose Combination Therapy and Polypills Forum. The forum will gather industry elites to jointly explore the immense potential of polypills in the field of cardiovascular health, as well as how they can significantly reduce cardiovascular disease mortality in the next decade. We firmly believe that this forum will bring new insights and momentum to the cardiovascular health industry, moving towards a healthier and more prosperous future together!
欢迎注册
会议时间：2024年6月27-30日
会议地点：上海国际会议中心
注册官网：www.occmd.org
Conference Dates：June 27-30, 2024
Conference Venue：Shanghai International Convention Center
Registration Website：www.occmd.org
审核：李新立 钱菊英 陆国平 徐亚伟
全面工作
传播矩阵
FOLLOW US
苏州工业园区东方华夏心血管健康研究院
电话：0512-68295918
邮箱：info@ccahouse.org
网址：https://www.ccahouse.org
地址：苏州工业园区水坊路36号姑苏会平江馆心脏之家
特别声明：以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布，本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.
